Department of Experimental and Clinical Neuropathology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawinskiego 5, 02-106 Warszawa, Poland.
Folia Neuropathol. 2009;47(4):300-5.
Development of cerebellum continues over an extremely long period of time extending from the early embryonic phase until the first postnatal years. During an extended time of maturation the cerebellum is vulnerable to harmful agents. A group of cytoplasmic proteins that may protect cells against injury are the calcium binding proteins, among others calbindin. The distribution of this protein is not well known in cerebellar pathology, thus in the present study the localisation and appearance of calbindin expressing Purkinje cells in different pathological conditions occurring at the time of cerebellar development was examined. The investigations were carried out on human maturing cerebellar cortex (age range 30 gestational weeks - 2 years) of cases with paraneoplastic cerebellar degeneration and cerebellar neuronal migration disturbances. The Purkinje cells located in cerebellar heterotopias and dysgenesias were morphologically well developed and strongly immunostained with calbindin antibody. In paraneoplastic cerebellar degeneration the progressive decrease of calbindin content and disintegration of Purkinje cells were observed. Our results show that intrauterine harmful agents that disturb migration of the cerebellar neurons do not affect the content of calbindin in misoriented neurons and that this protein may play a role in development of Purkinje cells located in heterotopias and cerebellar dysgenesias. The progressive decrease of calbindin content in the Purkinje cells undergoing degeneration and death during paraneoplastic changes in the cerebellum also supports the hypothesis that this protein is very important component of intracellular homeostasis in cerebellar neurons.
小脑的发育是一个极其漫长的过程,从胚胎早期一直持续到出生后的第一年。在成熟的很长一段时间里,小脑容易受到有害物质的影响。一组可能保护细胞免受损伤的细胞质蛋白是钙结合蛋白,其中包括钙结合蛋白。这种蛋白在小脑病理学中的分布尚不清楚,因此在本研究中,研究了在小脑发育过程中出现的不同病理条件下,钙结合蛋白表达的浦肯野细胞的定位和形态。研究对象为人正在成熟的小脑皮质(年龄范围为 30 孕周-2 岁),包括副肿瘤性小脑变性和小脑神经元移行障碍。位于小脑异位和发育不良的浦肯野细胞形态发育良好,用钙结合蛋白抗体强烈免疫染色。在副肿瘤性小脑变性中,观察到钙结合蛋白含量逐渐减少和浦肯野细胞解体。我们的结果表明,在宫内干扰小脑神经元移行的有害因素不会影响异位神经元中钙结合蛋白的含量,并且该蛋白可能在位于异位和小脑发育不良的浦肯野细胞发育中发挥作用。在副肿瘤性小脑变化过程中,退化和死亡的浦肯野细胞中钙结合蛋白含量逐渐减少,这也支持了这样一种假设,即该蛋白是小脑神经元细胞内稳态的重要组成部分。